Saturday 17 October 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 44.1%, free cash flow grew 141.2% and total debt rose 42.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

121.84 0.33 +0.27%

Follow HALO

Alert me

Market cap: $13.8B
P/E: 34.6×
Fwd P/E: 10.6×
Dividend yield: —
F-score: 5/9
Altman Z: 3.46
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	22.24	22.13	25.79	15.00	+8 more quarters Free account
P/S ratio Full definition →	5.52	5.06	5.77	6.92
P/FCF ratio Full definition →	11.39	11.44	12.51	11.62
P/Operating CF Full definition →	38.10	42.40	36.82	48.14
P/B ratio Full definition →	63.95	34.77	165.22	17.06
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	6.67	6.27	7.72	7.57
EV/EBITDA Full definition →	15.43	15.27	19.20	11.46
EV/Operating CF Full definition →	13.55	13.97	16.54	15.39
EV/FCF Full definition →	13.76	14.17	16.72	12.72
Quick Ratio Full definition →	1.99	2.14	3.30	1.25
Current Ratio Full definition →	2.71	2.76	4.66	1.59
Net Debt/EBITDA Full definition →	5.93	8.28	(31.07)	3.37
Debt/Assets Full definition →	83.29%	80.24%	84.85%	68.01%
Debt/Equity Full definition →	14.95	9.76	43.89	3.00
Asset Turnover Full definition →	0.72	0.62	0.61	0.57
Operating CF/Net income Full definition →	1.05	1.20	(1.55)	1.02
Capex/Depreciation Full definition →	(0.12)	(0.10)	(15.78)	20.34
Interest Coverage Full definition →	51.48	33.50	(18.91)	50.73
Research and Development Expense of Revenue Full definition →	5.75%	6.79%	70.12%	4.87%
Selling, General and Administrative Expense of Revenue Full definition →	11.85%	15.36%	17.05%	13.01%
Intangible Assets out of Total Assets Full definition →	0.58	0.57	0.62	0.34
Share Based Compensation of Revenue Full definition →	3.68%	4.42%	3.67%	3.43%
Graham Net Nets Full definition →	(0.16)	(0.19)	(0.20)	(0.05)
Graham Number Full definition →	9.85	11.05	4.89	21.75
Earnings Yield Full definition →	4.50%	4.52%	3.88%	6.67%
Free Cash Flow Yield Full definition →	8.78%	8.74%	7.99%	8.60%
Revenue per Share Full definition →	4.10	3.19	3.77	3.02
Operating CF per Share Full definition →	2.05	1.52	1.83	1.52
Capex per Share Full definition →	(0.04)	(0.03)	(3.76)	3.80
Free Cash Flow per Share Full definition →	2.02	1.49	(1.93)	5.33
Cash per Share Full definition →	1.97	2.70	1.19	5.99
Shareholders Equity per Share Full definition →	1.22	1.86	0.41	4.30
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.22	1.86	0.41	4.30
Free Cash Flow Full definition →	236.72	176.34	(231.27)	624.44
Working Capital Full definition →	588.59	639.83	648.12	491.52
Capital Expenditures Full definition →	(4.17)	(3.74)	(450.30)	445.84
Net Current Asset Value Full definition →	(1,500.84)	(1,450.05)	(1,651.30)	(388.57)
EV/EBIT Full definition →	18.58	18.48	22.98	12.76
Capex to Sales Full definition →	0.01	0.01	1.00	(1.26)
Price to Operating Income Full definition →	15.37	14.91	17.20	11.66
Other line items
Average Receivables Full definition →	386.08	381.31	374.86	315.89
Average Payables Full definition →	21.15	17.09	15.57	13.88
Average Inventory Full definition →	159.32	160.17	159.17	158.60
Average Assets Full definition →	2,315.65	2,434.63	2,294.40	2,169.63
Average Common Equity Full definition →	238.15	350.95	206.32	478.31

Fold the line items

Columns are period end dates

Stockrow Weekly